| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |